EE03510B1 - Tsisapriidi pikendatud vabastamisega ravimvorm suukaudseks manustamiseks, selle valmistamine ja kasutamine - Google Patents

Tsisapriidi pikendatud vabastamisega ravimvorm suukaudseks manustamiseks, selle valmistamine ja kasutamine

Info

Publication number
EE03510B1
EE03510B1 EE9700105A EE9700105A EE03510B1 EE 03510 B1 EE03510 B1 EE 03510B1 EE 9700105 A EE9700105 A EE 9700105A EE 9700105 A EE9700105 A EE 9700105A EE 03510 B1 EE03510 B1 EE 03510B1
Authority
EE
Estonia
Prior art keywords
cisapride
preparation
dosage form
oral administration
sustained release
Prior art date
Application number
EE9700105A
Other languages
English (en)
Estonian (et)
Other versions
EE9700105A (et
Inventor
Marie Victor Gilis Paul
Marie Jozef Jans Eugene
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE9700105A publication Critical patent/EE9700105A/xx
Publication of EE03510B1 publication Critical patent/EE03510B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cereal-Derived Products (AREA)
EE9700105A 1994-11-02 1995-10-25 Tsisapriidi pikendatud vabastamisega ravimvorm suukaudseks manustamiseks, selle valmistamine ja kasutamine EE03510B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203184 1994-11-02
PCT/EP1995/004198 WO1996014070A1 (en) 1994-11-02 1995-10-25 Cisapride extended release oral compositions

Publications (2)

Publication Number Publication Date
EE9700105A EE9700105A (et) 1997-12-15
EE03510B1 true EE03510B1 (et) 2001-10-15

Family

ID=8217338

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700105A EE03510B1 (et) 1994-11-02 1995-10-25 Tsisapriidi pikendatud vabastamisega ravimvorm suukaudseks manustamiseks, selle valmistamine ja kasutamine

Country Status (29)

Country Link
US (2) US6153623A (bg)
EP (1) EP0789572A1 (bg)
JP (1) JP3182423B2 (bg)
KR (1) KR100255521B1 (bg)
AP (1) AP658A (bg)
AR (1) AR001765A1 (bg)
AU (1) AU704284B2 (bg)
BG (1) BG63244B1 (bg)
BR (1) BR9509565A (bg)
CA (1) CA2203663C (bg)
CZ (1) CZ287844B6 (bg)
EE (1) EE03510B1 (bg)
FI (1) FI971856A0 (bg)
HR (1) HRP950539A2 (bg)
HU (1) HUT77887A (bg)
IL (1) IL115843A0 (bg)
MY (1) MY113092A (bg)
NO (1) NO312538B1 (bg)
NZ (1) NZ295166A (bg)
OA (1) OA10419A (bg)
PL (1) PL181470B1 (bg)
RO (1) RO116042B1 (bg)
RU (1) RU2143890C1 (bg)
SK (1) SK54297A3 (bg)
TR (1) TR199501351A2 (bg)
TW (1) TW466114B (bg)
UA (1) UA50721C2 (bg)
WO (1) WO1996014070A1 (bg)
ZA (1) ZA959221B (bg)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release
CA2232489A1 (en) * 1995-12-01 1997-06-12 Janssen Pharmaceutica N.V. Cisapride sustained release
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
JP2001507359A (ja) * 1997-01-03 2001-06-05 エラン コーポレーション ピーエルシー 徐放性シサプリドミニ錠剤製剤
JP2002504107A (ja) * 1997-06-11 2002-02-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ (+)−または(−)−シサプリドの即時放出性pH非依存的固形投薬剤形
TW407058B (en) 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
KR100660594B1 (ko) * 1999-03-31 2006-12-22 얀센 파마슈티카 엔.브이. 방출 조절형 제제중의 프리젤라틴화 전분
EP1060743A1 (en) * 1999-06-17 2000-12-20 Development Center For Biotechnology Oral cisapride dosage forms with an extended duration
DZ3473A1 (fr) 2000-09-29 2002-04-04 Solvay Pharm Bv Formulation pharmaceutique a liberation prolongee independante de la force ionique.
ATE408400T1 (de) * 2002-05-21 2008-10-15 Watson Lab Inc Pharmazeutische zusammensetzung mit verzögerter freisetzung
KR101082774B1 (ko) 2006-04-12 2011-11-11 닛뽕소다 가부시키가이샤 서방성 정제의 제조 방법
RU2356532C2 (ru) * 2007-06-01 2009-05-27 Открытое Акционерное Общество "Отечественные Лекарства" Фармацевтическая композиция проксодолола с контролируемым высвобождением
WO2010099508A1 (en) 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057525A (en) * 1981-10-01 1991-10-15 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
WO1993018755A1 (en) * 1992-03-25 1993-09-30 Depomed Systems, Incorporated Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
JPH08502032A (ja) * 1992-07-07 1996-03-05 セプラコア インコーポレーテッド 胃食道逆流疾患およびその他の障害を治療するために▲(−)▼シサプリドを使用する方法
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
FI971856A (fi) 1997-04-30
NZ295166A (en) 1999-03-29
KR100255521B1 (ko) 2000-05-01
EE9700105A (et) 1997-12-15
AP658A (en) 1998-08-17
JPH09511760A (ja) 1997-11-25
AP9700969A0 (en) 1997-04-30
OA10419A (en) 2001-12-06
HRP950539A2 (en) 1997-08-31
CA2203663A1 (en) 1996-05-17
US6274599B1 (en) 2001-08-14
AR001765A1 (es) 1997-12-10
AU3844795A (en) 1996-05-31
FI971856A0 (fi) 1997-04-30
HUT77887A (hu) 1998-09-28
MY113092A (en) 2001-11-30
RU2143890C1 (ru) 2000-01-10
AU704284B2 (en) 1999-04-15
CZ124497A3 (en) 1997-08-13
CZ287844B6 (en) 2001-02-14
ZA959221B (en) 1997-04-30
JP3182423B2 (ja) 2001-07-03
PL181470B1 (pl) 2001-07-31
WO1996014070A1 (en) 1996-05-17
CA2203663C (en) 2002-04-30
IL115843A0 (en) 1996-01-31
UA50721C2 (uk) 2002-11-15
BR9509565A (pt) 1997-09-16
US6153623A (en) 2000-11-28
PL319948A1 (en) 1997-09-01
MX9703249A (es) 1997-07-31
BG101401A (bg) 1997-12-30
TW466114B (en) 2001-12-01
NO971832D0 (no) 1997-04-21
TR199501351A2 (tr) 1996-06-21
EP0789572A1 (en) 1997-08-20
SK54297A3 (en) 1997-10-08
RO116042B1 (ro) 2000-10-30
BG63244B1 (bg) 2001-07-31
NO971832L (no) 1997-04-21
NO312538B1 (no) 2002-05-27

Similar Documents

Publication Publication Date Title
NO20003218L (no) Oral farmasøytisk doseringsform med forlenget frigivningsvirkning
EE04417B1 (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm, selle valmistamise meetod ja kasutamine
DE59712959D1 (de) Orale pharmazeutische zubereitung enthaltend ibandronat
EE03594B1 (et) Depooravimiks sobiv farmatseutiline kompositsioon, selle valmistamismeetod ja kasutamine
NO912607L (no) Fast, oral, farmasoeytisk doseringsform med programmert frigivning
NO975831L (no) Nytt farmasöytisk preparat med anestetisk virkning
EE04151B1 (et) Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena
EE04236B1 (et) Bensimidasoolid, nende valmistamine ja kasutamineravimitena
EE200000723A (et) Asendatud indolinoonid, nende valmistamine ja nende kasutamine ravimitena
EE04497B1 (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
IS3878A (is) Imidazodiazepines efnasambönd, framleiðsla þeirraog notkun sem lyfja
EE200200160A (et) 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid
EE04997B1 (et) Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
EE04955B1 (et) Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
EE03510B1 (et) Tsisapriidi pikendatud vabastamisega ravimvorm suukaudseks manustamiseks, selle valmistamine ja kasutamine
PT868911E (pt) Formulacoes de rapamicina para administracao oral
NO20002526D0 (no) Mellomprodukt med høyt legemiddelinnhold og orale doseringspreparater med modifisert frigivelse samt fremgangsmÕter for fremstilling derav
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
EE04260B1 (et) Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine
EE03387B1 (et) Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks
EE200200551A (et) Oligosahhariide sisaldav farmatseutiline kompositsioon, oligosahhariidid, nende valmistamine ja raviotstarbeline kasutamine
IT1291823B1 (it) Composti pseudo-peptidici, loro preparazione ed uso in formulazioni farmaceutiche
FI956251A (fi) 1-okso-2-(fenyylisulfonyyliamino)pentyylipiperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20041025